(lp0
S'DARA BioSciences Announces Stockholder Approval of Merger With Midatech Marketwired  - Dec 2, 2015 RALEIGH, NC-- - DARA BioSciences, Inc. , an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer&nbsp;...Stock Update : DARA Biosciences Inc Announces Stockholder ... - Smarter Analyst'
p1
aS'DARA BIOSCIENCES, INC. SHAREHOLDER ALERT: Rigrodsky &amp; Long, PA Announces ... PR Newswire  - Jun 10, 2015 Rigrodsky &amp; Long, P.A. announces that it is investigating potential legal claims against the board of directors of DARA BioSciences, Inc.   regarding possible breaches of fiduciary duties and other violations ...'
p2
aS'DARA BioSciences Announces Acquisition of US Marketing Rights to Soltamox(TM ... GlobeNewsWire  - Jan 17, 2012 RALEIGH, N.C., Jan. 17, 2012  -- DARA BioSciences, Inc.  announced today that it has acquired exclusive U.S.'
p3
aS"Raleigh's Dara to merge with UK pharma company Triangle Business Journal - Jun 4, 2015 Raleigh-based Dara BioSciences, Inc. , which faced being delisted from Nasdaq, reached a merger deal with Midatech Pharma, based in Oxford, United Kingdom.DARA BioSciences , Midatech Pharma Enter Merger Agreement - StreetInsider.com"
p4
aS'Stock Update : DARA Biosciences Inc Announces Second Quarter 2015 ... Smarter Analyst - Aug 12, 2015 DARA Biosciences Inc , an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects&nbsp;...'
p5
aS'DARA BioSciences Obtains US Rights to Co-Promote Bionect, an FDA Approved ... GlobeNewsWire  - Mar 26, 2012 RALEIGH, N.C., March 26, 2012  -- DARA BioSciences, Inc.  announced today that it entered into an exclusive agreement with Innocutis Holdings, LLC  for U.S.'
p6
aS'DARA BioSciences Launches Oral Mucositis Care App to Provide Cancer Patients ... Business Wire  - Jun 3, 2014 RALEIGH, N.C.----DARA BioSciences, Inc. , an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to their&nbsp;...'
p7
aS"Pulling the Curtain Back on DARA Biosciences, Inc.  Earnings ... Melville Review - Mar 24, 2017 Wall Street is predicting that DARA Biosciences, Inc. 's earnings per share  will be $N/A when the firm is expected to announce earnings around N/A."
p8
aS'DARA Biosciences, Inc.  Reviewed By Analysts The De Soto Edge - Mar 5, 2017 Stock market analysts watching DARA Biosciences, Inc.  have recently changed their ratings on the stock. The latest reports which are outstanding on Sunday 5th of March state 0 analysts have a rating of strong buy, 0 analysts buy, 0 analysts&nbsp;...'
p9
aS', First and Only Liquid Version of Tamoxifen Citrate Business Wire  - Oct 22, 2012 Introduced by DARA BioSciences, Inc. , a specialty pharmaceutical company focused on oncology and oncology supportive care products, Soltamox, a prescription medication, is expected to be available in pharmacies nationwide starting&nbsp;...'
p10
a.